---
title: "688246.SH (688246.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688246.SH/news.md"
symbol: "688246.SH"
name: "688246.SH"
parent: "https://longbridge.com/en/quote/688246.SH.md"
datetime: "2026-03-10T04:22:51.110Z"
locales:
  - [en](https://longbridge.com/en/quote/688246.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688246.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688246.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688246.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688246.SH/news.md)


# 688246.SH (688246.SH) — Related News

### [GOODWILL: Net profit loss of 253 million yuan in 2025](https://longbridge.com/en/news/277164574.md)
*2026-02-27T08:31:44.000Z*
> GOODWILL announced that the operating revenue for the fiscal year 2025 was 408 million yuan, a year-on-year decrease of 

### [](https://longbridge.com/en/news/275303210.md)
*2026-02-09T10:42:57.000Z*
> In January, Jiawei's revenue was 566 million yuan

### [](https://longbridge.com/en/news/274776522.md)
*2026-02-04T07:55:57.000Z*
> Carlsberg CEO: Trade policies will be the biggest factor determining the consumer environment in 2026

### [Daiichi Sankyo/AstraZeneca's "Deruxtecan" approved in China for the treatment of HER2-positive gastric cancer](https://longbridge.com/en/news/273474639.md)
*2026-01-23T06:49:17.000Z*
> On January 22, Daiichi Sankyo and AstraZeneca announced that injectable deruxtecan has been approved by the National Med

### [AstraZeneca announces that PD-L1 monoclonal antibody has been approved for a new indication in China targeting endometrial cancer](https://longbridge.com/en/news/273474092.md)
*2026-01-23T06:45:05.000Z*
> AstraZeneca announced on January 22 that its PD-L1 monoclonal antibody Imfinzi® (durvalumab) has been approved by the Na

### [Data Element Industry Weekly Report (01.14 - 01.21): Release of Data Element Value](https://longbridge.com/en/news/273297166.md)
*2026-01-22T00:27:44.000Z*
> This week's data element industry dynamics: The Deputy Governor of the Central Bank, Zou Lan, stated that the financial 

### [](https://longbridge.com/en/news/272627192.md)
*2026-01-15T01:50:54.000Z*
> AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma

### [AI medical concept repeatedly active, R&G Pharma 20cm two consecutive limit-ups](https://longbridge.com/en/news/272485616.md)
*2026-01-14T02:19:47.000Z*
> The AI medical concept is repeatedly active, R&G Pharma has a two-day limit up of 20cm, ClinPlus, GOODWILL, and Winning 

### [GOODWILL: Shareholders holding more than 5% of shares did not reduce their holdings as planned upon expiration](https://longbridge.com/en/news/272050634.md)
*2026-01-09T09:12:20.000Z*
> GOODWILL announced that the shareholding reduction plan of its shareholder Hongyun Jiukang has expired, but no shares we